FBIO

Fortress Biotech, Inc.

SEC CIK 1429260
$3.07 −16.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
47
Most recent
Advertisement

At a glance

Insiders at FBIO have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.

Largest recent trade: Rosenwald Lindsay A Md, FBIO's CEO, spent $2.66M of their own money on 1.57M shares at $2, growing their stake 152%.

Most active filer: Rosenwald Lindsay A Md, with 16 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for FBIO, newest first
View on SEC EDGAR ↗
FBIO
Buy ROSENWALD LINDSAY A MD · Director, President, CEO & Chairman, 10% Owner · Open-market purchase · filed Jul 11, 2024 ΔOwn +4.3%

Rosenwald Lindsay A Md, FBIO's CEO, spent $37K of their own money on 5,000 shares at $7, growing their stake 4%.

+$37K
5,000 sh @ $7
FBIO
Buy ROSENWALD LINDSAY A MD · Director, President, CEO & Chairman, 10% Owner · Open-market purchase · filed Jul 10, 2024 ΔOwn +4.4%

Rosenwald Lindsay A Md, FBIO's CEO, spent $36.8K of their own money on 5,000 shares at $7, growing their stake 4%.

+$36.8K
5,000 sh @ $7
FBIO
Buy ROSENWALD LINDSAY A MD · Director, President, CEO & Chairman, 10% Owner · Open-market purchase · filed Jul 1, 2024 ΔOwn +0.7%

Rosenwald Lindsay A Md, FBIO's CEO, spent $32.7K of their own money on 20,000 shares at $2, growing their stake 1%.

+$32.7K
20,000 sh @ $2
FBIO
Sell Klein Dov · Director · Open-market sale · filed May 20, 2024 ΔOwn −16%

Klein Dov sold $18.9K of FBIO, trimming their stake 16%.

−$18.9K
10,000 sh @ $2
FBIO
Buy ROSENWALD LINDSAY A MD · Director, President, CEO & Chairman, 10% Owner · Open-market purchase · filed May 20, 2024 ΔOwn +0.3%

Rosenwald Lindsay A Md, FBIO's CEO, spent $17.6K of their own money on 10,000 shares at $2.

+$17.6K
10,000 sh @ $2
Advertisement
FBIO
Buy ROSENWALD LINDSAY A MD · Director, President, CEO & Chairman, 10% Owner · Open-market purchase · filed Jan 9, 2024 ΔOwn +1.8%

Rosenwald Lindsay A Md, FBIO's CEO, spent $118.8K of their own money on 50,000 shares at $2, growing their stake 2%.

+$118.8K
50,000 sh @ $2
FBIO
Buy ROSENWALD LINDSAY A MD · Director, President, CEO & Chairman, 10% Owner · Open-market purchase · filed Nov 16, 2023 ΔOwn +152%

Rosenwald Lindsay A Md, FBIO's CEO, spent $2.66M of their own money on 1.57M shares at $2, growing their stake 152%.

+$2.66M
1.57M sh @ $2
FBIO
Buy WEISS MICHAEL S · Director, See Remarks · Open-market purchase · filed Nov 16, 2023 ΔOwn +15%

Weiss Michael S, FBIO's Director, spent $250K of their own money on 147,058 shares at $2, growing their stake 15%.

+$250K
147,058 sh @ $2
FBIO
Buy ROSENWALD LINDSAY A MD · Director, President, CEO & Chairman, 10% Owner · Open-market purchase · filed Sep 27, 2023 ΔOwn +0.7%

Rosenwald Lindsay A Md, FBIO's CEO, spent $28.3K of their own money on 100,000 shares at $0, growing their stake 1%.

+$28.3K
100,000 sh @ $0
FBIO
Buy ROSENWALD LINDSAY A MD · Director, President, CEO & Chairman, 10% Owner · Open-market purchase · filed Aug 21, 2023 ΔOwn +9.8%

Rosenwald Lindsay A Md, FBIO's CEO, spent $93.4K of their own money on 10,000 shares at $9, growing their stake 10%.

+$93.4K
10,000 sh @ $9
FBIO
Buy ROSENWALD LINDSAY A MD · Director, President, CEO & Chairman, 10% Owner · Open-market purchase · filed Aug 21, 2023 ΔOwn +11%

Rosenwald Lindsay A Md, FBIO's CEO, spent $117.5K of their own money on 10,000 shares at $12, growing their stake 11%.

+$117.5K
10,000 sh @ $12
FBIO
Buy WEISS MICHAEL S · Director, See Remarks, 10% Owner · Open-market purchase · filed Feb 14, 2023 ΔOwn +8.8%

Weiss Michael S, FBIO's 10% owner, spent $1,000K of their own money on 1.2M shares at $1, growing their stake 9%.

+$1,000K
1.2M sh @ $1
FBIO
Buy ROSENWALD LINDSAY A MD · Director, President, CEO & Chairman, 10% Owner · Open-market purchase · filed Feb 14, 2023 ΔOwn +18%

Rosenwald Lindsay A Md, FBIO's CEO, spent $2M of their own money on 2.4M shares at $1, growing their stake 18%.

+$2M
2.4M sh @ $1
FBIO
Buy LOBELL J JAY · Director · Open-market purchase · filed Feb 14, 2023 ΔOwn +22%

Lobell J Jay, FBIO's Director, spent $250K of their own money on 299,401 shares at $1, growing their stake 22%.

+$250K
299,401 sh @ $1
FBIO
Buy ROSENWALD LINDSAY A MD · Director, PRESIDENT, CEO & CHAIRMAN, 10% Owner · Open-market purchase · filed Dec 5, 2022 ΔOwn +0.9%

Rosenwald Lindsay A Md, FBIO's CEO, spent $68K of their own money on 100,000 shares at $1, growing their stake 1%.

+$68K
100,000 sh @ $1
FBIO
Buy ROSENWALD LINDSAY A MD · Director, PRESIDENT, CEO & CHAIRMAN, 10% Owner · Open-market purchase · filed Dec 2, 2022

Rosenwald Lindsay A Md, FBIO's CEO, spent $2.8K of their own money on 5,000 shares at $1.

+$2.8K
5,000 sh @ $1
FBIO
Buy ROSENWALD LINDSAY A MD · Director, PRESIDENT, CEO & CHAIRMAN, 10% Owner · Open-market purchase · filed Oct 24, 2022 ΔOwn +0.9%

Rosenwald Lindsay A Md, FBIO's CEO, spent $69.5K of their own money on 100,000 shares at $1, growing their stake 1%.

+$69.5K
100,000 sh @ $1
Advertisement

About FBIO insider activity

This page tracks every recent Form 4 filed for Fortress Biotech, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is FBIO insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Fortress Biotech, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.